Opportunities and methods for studying alternative splicing in cancer with RNA-Seq

Cancer Letters

Volumn 340, Issue 2, 2013, Pages 179-191

  Feng, Huijuan ^a   Qin, Zhiyi ^a   Zhang, Xuegong ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

Alternative splicing; Bioinformatics; Cancer; RNA Seq; Transcriptomes

Indexed keywords

DNA; MEMBRANE PROTEIN; MICRORNA; RNA; TRANSCRIPTOME;

ALTERNATIVE RNA SPLICING; BIOGENESIS; BREAST CANCER; DNA MICROARRAY; GENE MUTATION; HIGH THROUGHPUT SEQUENCING; HUMAN; METASTASIS; NEOPLASM; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; PROSTATE CANCER; QUANTITATIVE ANALYSIS; RNA SEQUENCE; SHORT SURVEY; TUMOR GROWTH;

EID: 84887617966     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.11.010     Document Type: Review

References (84)

1. DeRisi J., Penland L., Brown P.O., Bittner M.L., Meltzer P.S., Ray M., Chen Y., Su Y.A., Trent J.M. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nature Genetics 1996, 14:457-460.
2. Kononen J., Bubendorf L., Kallionimeni A., Bärlund M., Schraml P., Leighton S., Torhorst J., Sauter G., Kallioniemi O.P. Tissue microarrays for high-throughtput molecular profiling of tumor specimens. Nature Medicine 1998, 4:844-847.
3. Golub T.R., Slonim D.K., Tamayo P., Huard C., Gaasenbeek M., Mesiroy J.P., Coller H., Loh M.L., Downing J.R., Caligiuri M.A., Bloomfield C.D., Lander E.S. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999, 286:531-537.
4. van 't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A.M., Mao M., Peterse H.L., van der Kooy K., Marton M.J., Witteveen A.T., Schreiber G.J., Kerkhoven R.M., Roberts C., Linsley P.S., Bernards R., Friend S.H. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536.
5. http://www.nature.com/news/2007/070205/full/news070205-7.html.
6. Venables J.P. Aberrant and alternative splicing in cancer. Cancer Research 2004, 64:7647-7654.
7. Garcia-Blanco M.A., Baraniak A.P., Lasda E.L. Alternative splicing in disease and therapy. Nature Biotechnology 2004, 22:535-546.
8. Shendure J., Ji H. Next-generation DNA sequencing. Nature Biotechnology 2008, 26:1135-1145.
9. Shah S.P., Köbel M., Senz J., Morin R.D., Clarke B.A., Wiegand K.C., Leung G., Zayed A., Mehl E., Kalloger S.E., Sun M., Giuliany R., Yorida E., Jones S., Varhol R., Swenerton K.D., Miller D., Clement P.B., Crane C., Madore J., Provencher D., Leung P., DeFazio A., Khattra J., Turashvili G., Zhao Y., Zeng T., Glover J.N., Vanderhyden B., Zhao C., Parkinson C.A., Jimenez-Linan M., Bowtell D.D., Mes-Masson A.M., Brenton J.D., Aparicio S.A., Boyd N., Hirst M., Gilks C.B., Marra M., Huntsman D.G. Mutation of FOXL2 in granulosa-cell tumors of the ovary. The New England Journal of Medicine 2009, 360:2719-2729.
10. Morin R., Bainbridge M., Fejes A., Hirst M., Krzywinski M., Pugh T., McDonald H., Varhol R., Jones S., Marra M. Profiling the HeLa S3 transcriptome using randomly primed cDNA and massively parallel short-read sequencing. BioTechniques 2008, 45:81-94.
11. Berger M.F., Levin J.Z., Vijayendran K., Sivachenko A., Adiconis X., Maguire J., Johnson L.A., Robinson J., Verhaak R.G., Sougnez C., Onofrio R.C., Ziaugra L., Cibulskis K., Laine E., Barretina J., Winckler W., Fisher D.E., Getz G., Meyerson M., Jaffe D.B., Gabriel S.B., Lander E.S., Dummer R., Gnirke A., Nusbaum C., Garraway L.A. Integrative analysis of the melanoma transcriptome. Genome Research 2010, 20:413-427.
12. Kannan K., Wang L., Wang J., Ittmann M.M., Li W., Yen L. Recurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencing. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:9172-9177.
13. Kalari K.R., Rossell D., Necela B.M., Asmann Y.W., Nair A., Baheti S., Kachergus J.M., Younkin C.S., Baker T., Carr J.M., Tang X., Walsh M.P., Chai H.S., Sun Z., Hart S.N., Leontovich A.A., Hossain A., Kocher J.P., Perez E.A., Reisman D.N., Fields A.P., Thompson E.A. Deep sequence analysis of non-small cell lung cancer: integrated analysis of gene expression, alternative splicing, and single nucleotide variations in lung adenocarcinomas with and without oncogenic KRAS mutations. Frontiers in Oncology 2012, 2:12.
14. Kim Y.H., Liang H., Liu X., Lee J.-S., Cho J.Y., Cheong J.H., Kim H., Li M., Downey T.J., Dyer M.D., Sun Y., Sun J., Beasley E.M., Chung H.C., Noh S.H., Weinstein J.N., Liu C.G., Powis G. AMPKα modulation in cancer progression: multilayer integrative analysis of the whole transcriptome in Asian gastric cancer. Cancer Research 2012, 72:2512-2521.
15. Bahn J.H., Lee J.H., Li G., Greer C., Peng G., Xiao X. Accurate identification of A-to-I RNA editing in human by transcriptome sequencing. Genome Research 2012, 22:142-150.
16. Gu T., Buaas F.W., Simons A.K., Ackert-Bicknell C.L., Braun R.E., Hibbs M.A. Canonical A-to-I and C-to-U RNA editing is enriched at 3'UTRs and microRNA target sites in multiple mouse tissues. PLoS ONE 2012, 7:e33720.
17. Maher C.A., Palanisamy N., Brenner J.C., Cao X., Kalyana-Sundaram S., Luo S., Khrebtukova I., Barrette T.R., Grasso C., Yu J., Lonigro R.J., Schroth G., Kumar-Sinha C., Chinnaiyan A.M. Chimeric transcript discovery by paired-end transcriptome sequencing. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:12353-12358.
18. Maher C.A., Kumar-Sinha C., Cao X., Kalyana-Sundaram S., Han B., Jing X., Sam L., Barrette T., Palanisamy N., Chinnaiyan A.M. Transcriptome sequencing to detect gene fusions in cancer. Nature 2009, 458:97-101.
19. Steidl C., Shah S.P., Woolcock B.W., Rui L., Kawahara M., Farinha P., Johnson N.A., Zhao Y., Telenius A., Neriah S.B., McPherson A., Meissner B., Okoye U.C., Diepstra A., van den Berg A., Sun M., Leung G., Jones S.J., Connors J.M., Huntsman D.G., Savage K.J., Rimsza L.M., Horsman D.E., Staudt L.M., Steidl U., Marra M.A., Gascoyne R.D. MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature 2011, 471:377-381.
20. Edgren H., Murumagi A., Kangaspeska S., Nicorici D., Hongisto V., Kleivi K., Rye I.H., Nyberg S., Wolf M., Borresen-Dale A.L., Kallioniemi O. Identification of fusion genes in breast cancer by paired-end RNA-sequencing. Genome Biology 2011, 12:R6.
21. Pflueger D., Terry S., Sboner A., Habegger L., Esgueva R., Lin P.C., Svensson M.A., Kitabayashi N., Moss B.J., MacDonald T.Y., Cao X., Barrette T., Tewari A.K., Chee M.S., Chinnaiyan A.M., Rickman D.S., Demichelis F., Gerstein M.B., Rubin M.A. Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing. Genome Research 2011, 21:56-67.
22. Pflueger D., Rickman D.S., Sboner A., Perner S., Lafargue C.J., Svensson M.A., Moss B.J., Kitabayashi N., Pan Y., de la Taille A., Kuefer R., Tewari A.K., Demichelis F., Chee M.S., Gerstein M.B., Rubin M.A. N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer. Neoplasia 2009, 11:804-811.
23. Levin J.Z., Berger M.F., Adiconis X., Rogov P., Melnikov A., Fennell T., Nusbaum C., Garraway L.A., Gnirke A. Targeted next-generation sequencing of a cancer transcriptome enhances detection of sequence variants and novel fusion transcripts. Genome Biology 2009, 10:R115.
24. Wang X.S., Prensner J.R., Chen G., Cao Q., Han B., Dhanasekaran S.M., Ponnala R., Cao X., Varambally S., Thomas D.G., Giordano T.J., Beer D.G., Palanisamy N., Sartor M.A., Omenn G.S., Chinnaiyan A.M. An integrative approach to reveal driver gene fusions from paired-end sequencing data in cancer. Nature Biotechnology 2009, 27:1005-1011.
25. Hegyi H., Buday L., Tompa P. Intrinsic structural disorder confers cellular viability on oncogenic fusion proteins. PLoS Computational Biology 2009, 5:e1000552.
26. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nature Reviews Cancer 2006, 6:857-866.
27. Prensner J.R., Chinnaiyan A.M. The emergence of lncRNAs in cancer biology. Cancer Discovery 2011, 1:391-407.
28. Huarte M., Rinn J.L. Large non-coding RNAs: missing links in cancer?. Human Molecular Genetics 2010, 19:R152-61.
29. Persson H., Kvist A., Rego N., Staaf J., Vallon-Christersson J., Luts L., Loman N., Jonsson G., Naya H., Hoglund M., Borg A., Rovira C. Identification of new microRNAs in paired normal and tumor breast tissue suggests a dual role for the ERBB2/Her2 gene. Cancer Research 2011, 71:78-86.
30. Prensner J.R., Iyer M.K., Balbin O.A., Dhanasekaran S.M., Cao Q., Brenner J.C., Laxman B., Asangani I.A., Grasso C.S., Kominsky H.D., Cao X., Jing X., Wang X., Siddiqui J., Wei J.T., Robinson D., Iyer H.K., Palanisamy N., Maher C.A., Chinnaiyan A.M. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nature Biotechnology 2011, 29:742-749.
31. Flockhart R.J., Webster D.E., Qu K., Mascarenhas N., Kovalski J., Kretz M., Khavari P.A. BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration. Genome Research 2012, 22:1006-1014.
32. Ren S., Peng Z., Mao J.H., Yu Y., Yin C., Gao X., Cui Z., Zhang J., Yi K., Xu W., Chen C., Wang F., Guo X., Lu J., Yang J., Wei M., Tian Z., Guan Y., Tang L., Xu C., Wang L., Gao X., Tian W., Wang J., Yang H., Wang J., Sun Y. RNA-Seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. Cell Research 2012, 22:806-821.
33. Wang Z., Gerstein M., Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nature Reviews Genetics 2009, 10:57-63.
34. Matlin A.J., Clark F., Smith C.W.J. Understanding alternative splicing: towards a cellular code. Nature Reviews Molecular Cell Biology 2005, 6:386-398.
35. Wen F., Li F., Xia H., Lu X., Zhang X., Li Y. The impact of very short alternative splicing on protein structures and functions in the human genome. Trends in Genetics 2004, 20:232-236.
36. Stamm S., Ben-Ari S., Rafalska I., Tang Y., Zhang Z., Toiber D., Thanaraj T.A., Soreg H. Function of alternative splicing. Gene 2005, 344:1-20.
37. Graveley B.R. Alternative splicing: increasing diversity in the proteomic world. Trends in Genetics 2001, 17:100-107.
38. Modrek B., Lee C. A genomic view of alternative splicing. Nature Genetics 2002, 30:13-19.
39. Chen M., Manley J.L. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nature Reviews Molecular Cell Biology 2009, 10:741-754.
40. Wang E.T., Sandberg R., Luo S., Khrebtukova I., Zhang L., Mayr C., Kingsmore S.F., Schroth G.P., Burge C.B. Alternative isoform regulation in human tissue transcriptomes. Nature 2008, 456:470-476.
41. Pan Q., Shai O., Lee L.J., Frey B.J., Blencowe B.J. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nature Genetics 2008, 40:1413-1415.
42. Garcia-Blanco M.A., Baraniak A.P., Lasda E.L. Alternative splicing in disease and therapy. Nature Biotechnology 2004, 22:535-546.
43. Wang L., Duke L., Zhang P.S., Arlinghaus R.B., Symmans W.F., Sahin A., Mendez R., Dai J.L. Alternative splicing disrupts a nuclear localization signal in spleen kyrosine kinase that is required for invasion suppression in breast cancer. Cancer Research 2003, 63:4724-4730.
44. Goodman P.A., Wood C.M., Vassilev A., Mao C., Uckun F.M. Spleen tyrosine kinase (Syk) deficiency in childhood pro-B cell acute lymphoblastic leukemia. Oncogene 2001, 20:3969-3978.
45. Nakashima H., Natsugoe S., Ishigami S., Okumura H., Matsumoto M., Hokita S., Aikou T. Clinical significance of nuclear expression of spleen tyrosine kinase (Syk) in gastric cancer. Cancer Letters 2006, 236:89-94.
46. Prinos P., Garneau D., Lucier J.F., Gendron D., Couture S., Boivin M., Brosseau J.P., Lapointe E., Thibault P., Durand M., Tremblay K., Gervais-Bird J., Nwilati H., Klinck R., Chabot B., Perreault J.P., Wellinger R.J., Elela S.A. Alternative splicing of SYK regulates mitosis and cell survival. Nature Structural and Molecular Biology 2011, 18:673-679.
47. Skotheim R.I., Nees M. Alternative splicing in cancer: noise, functional, or systematic?. The International Journal of Biochemistry and Cell Biology 2007, 39:1432-1449.
48. Zhang C., Li H.R., Fan J.B., Wang-Rodriguez J., Downs T., Fu X.D., Zhang M.Q. Profiling alternatively spliced mRNA isoforms for prostate cancer classification. BMC Bioinformatics 2006, 7:202.
49. Gardina P.J., Clark T.A., Shimada B., Staples M.K., Yang Q., Veitch J., Schweitzer A., Awad T., Sugnet C., Dee S., Davies C., Williams A., Turpaz Y. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array. BMC Genomics 2006, 7:325.
50. Thorsen K., Sørensen K.D., Brems-eskildsen A.S., Modin C., Gaustadnes M., Hein A.M., Kruhøffer M., Laurberg S., Borre M., Wang K., Brunak S., Krainer A.R., Tørring N., Dyrskjøt L., Andersen C.L., Orntoft T.F. Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis. Molecular and Cellular Proteomics 2008, 7:1214-1224.
51. Xi L., Feber A., Gupta V., Wu M., Bergemann A.D., Landreneau R.J., Litle V.R., Pennathur A., Luketich J.D., Godfrey T.E. Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer. Nucleic Acids Research 2008, 36:6535-6547.
52. Lapuk A., Marr H., Jakkula L., Pedro H., Bhattacharya S., Purdom E., Hu Z., Simpson K., Pachter L., Durinck S., Wang N., Parvin B., Fontenay G., Speed T., Garbe J., Stampfer M., Bayandorian H., Dorton S., Clark T.A., Schweitzer A., Wyrobek A., Feiler H., Spellman P., Conboy J., Gray J.W. Exon-level microarray analyses identify alternative splicing programs in breast cancer. Molecular Cancer Research 2010, 8:961-974.
53. Sultan M., Schulz M.H., Richard H., Magen A., Klingenhoff A., Scherf M., Seifert M., Borodina T., Soldatov A., Parkhomchuk D., Schmidt D., O'Keeffe S., Haas S., Vingron M., Lehrach H., Yaspo M.L. A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science 2008, 321:956-960.
54. Mortazavi A., Williams B.A., Mccue K., Schaeffer L., Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nature Methods 2008, 5:621-628.
55. Tang F., Barbacioru C., Wang Y., Nordman E., Lee C., Xu N., Wang X., Bodeau J., Tuch B.B., Siddiqui A., Lao K., Surani M.A. mRNA-Seq whole-transcriptome analysis of a single cell. Nature Method 2009, 6:377-382.
56. Wu Y., Wang X., Wu F., Huang R., Xue F., Liang G., Tao M., Cai P., Huang Y. Transcriptome profiling of the cancer, adjacent non-tumor and distant normal tissues from a colorectal cancer patient by deep sequencing. PLoS ONE 2012, 7:e41001.
57. Huang Q., Lin B., Liu H., Ma X., Mo F., Yu W., Li L., Li H., Tian T., Wu D., Shen F., Xing J., Chen Z.N. RNA-Seq analyses generate comprehensive transcriptomic landscape and reveal complex transcript patterns in hepatocellular carcinoma. PLoS ONE 2011, 6:e26168.
58. Shapiro I.M., Cheng A.W., Flytzanis N.C., Balsamo M., Condeelis J.S., Oktay M.H., Burge C.B., Gertler F.B. An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genetics 2011, 7:e1002218.
59. Li H., Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009, 25:1754-1760.
60. Langmead B., Trapnell C., Pop M., Salzberg S.L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biology 2009, 10:R25.
61. Li R., Li Y., Kristiansen K., Wang J. SOAP: short oligonucleotide alignment program. Bioinformatics 2008, 24:713-714.
62. Li H., Ruan J., Durbin R. Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Research 2008, 18:1851-1858.
63. Trapnell C., Pachter L., Salzberg S.L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009, 25:1105-1111.
64. Au K.F., Jiang H., Lin L., Xing Y., Wong W.H. Detection of splice junctions from paired-end RNA-Seq data by SpliceMap. Nucleic Acids Research 2010, 38:4570-4578.
65. Wang L., Wang X., Wang X., Liang Y., Zhang X. Observations on novel splice junctions from RNA sequencing data. Biochemical and Biophysical Research Communications 2011, 409:299-303.
66. Jiang H., Wong W.H. Statistical inferences for isoform expression in RNA-Seq. Bioinformatics 2009, 25:1026-1032.
67. Wang X., Wu Z., Zhang X. Isoform abundance inference provides a more accurate estimation of gene expression levels in RNA-Seq. Journal of Bioinformatics and Computational Biology 2010, 8:177.
68. Trapnell C., Williams B.A., Pertea G., Mortazavi A., Kwan G., van Baren M.J., Salzberg S.L., Word B.J., Pachter L. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nature Biotechnology 2010, 28:511-515.
69. Katz Y., Wang E.T., Airoldi E.M., Burge C.B. Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nature Methods 2010, 7:1009-1015.
70. Wu Z., Wang X., Zhang X. Using non-uniform read distribution models to improve isoform expression inference in RNA-Seq. Bioinformatics 2011, 27:502-508.
71. Li B., Ruotti V., Stewart R.M., Thomson J.A., Dewey C.N. RNA-Seq gene expression estimation with read mapping uncertainty. Bioinformatics 2010, 26:493-500.
72. Roberts A., Trapnell C., Donaghey J., Rinn J.L., Pachter L. Improving RNA-Seq expression estimates by correcting for fragment bias. Genome Biology 2011, 12:R22.
73. Blencowe B.J., Ahmad S., Lee L.J. Current-generation high-throughput sequencing: deepening insights into mammalian transcriptomes. Genes and Development 2009, 23:1379-1386.
74. Wang L., Feng Z., Wang X., Wang X., Zhang X. DEGseq: an R package for identifying differentially expressed genes from RNA-Seq data. Bioinformatics 2010, 26:136-138.
75. Robinson M.D., McCarthy D.J., Smyth G.K. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010, 26:139-140.
76. Anders S., Huber W. Differential expression analysis for sequence count data. Genome Biology 2010, 11:R106.
77. Hardcastle T.J., Kelly K.A. BaySeq: empirical Bayesian methods for identifying differential expression in sequence count data. BMC Bioinformatics 2010, 11:422.
78. Stegle O., Drewe P., Bohnert R., Borgwardt K.M., Gunnar R. Statistical tests for detecting differential RNA-transcript expression from read counts. Nature Proceedings 2010, 1-11. 10.1038/npre.2010.4437.1.
79. Singh D., Orellana C.F., Hu Y., Jones C.D., Liu Y., Chiang D.Y., Liu J., Prins J.F. FDM: a graph-based statistical method to detect differential transcription using RNA-Seq data. Bioinformatics 2011, 27:2633-2640.
80. Shen S., Park J.W., Huang J., Dittmar K.A., Lu Z., Zhou Q., Carstens R.P., Xing Y. MATS: a Bayesian framework for flexible detection of differential alternative splicing from RNA-Seq data. Nucleic Acids Research 2012, 40:e61.
81. W. Wang, Z. Qin, Z. Feng, X. Wang, X. Zhang, Identifying differentially spliced genes from two groups of RNA-Seq samples, Gene (2012). http://dx.doi.org/10.1016/j.gene.2012.11.045.
82. Guttman M., Garber M., Levin J.Z., Donaghey J., Robinson J., Adiconis X., Fan L., Kiziol M.J., Gnirke A., Nusbaum C., Rinn J.L., Lander E.S., Regev A. Ab initio reconstruction of cell type-specific transcriptomes in mouse reveals the conserved multi-exonic structure of lincRNAs. Nature Biotechnology 2010, 28:503-510.
83. Garber M., Grabherr M.G., Guttman M., Trapnell C. Computational methods for transcriptome annotation and quantification using RNA-Seq. Nature Methods 2011, 8:469-477.
84. Li H., Handsaker B., Wysoker A., Fennel T., Ruan J., Homer N., Marth G., Abecasis G., Durbin R. 1000 Genome project data processing subgroup, the sequence alignment/map (SAM) format and SAMtools. Bioinformatics 2009, 25:2078-2079.